We just received data on a new analyst forecast for $AVTX. Julian Harrison from BTIG set a price target of 58.0 for AVTX.
To track analyst ratings and price targets for $AVTX, check out Quiver Quantitative's $AVTX forecast page.
Should you buy $AVTX?
Some analysts are better than others. To view the past performance of BTIG, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$AVTX Price Targets
Multiple analysts have issued price targets for $AVTX recently. We have seen 6 analysts offer price targets for $AVTX in the last 6 months, with a median target of $49.0.
Here are some recent targets:
- Julian Harrison from BTIG set a target price of $58.0 on 05/06/2026
- Andy Chen from Wolfe Research set a target price of $48.0 on 04/09/2026
- Jason Butler from Citizens set a target price of $52.0 on 04/06/2026
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $40.0 on 03/25/2026
- Yatin Suneja from Guggenheim set a target price of $50.0 on 02/02/2026
- Joseph Catanzaro from Mizuho set a target price of $39.0 on 12/18/2025
$AVTX Insider Trading Activity
$AVTX insiders have traded $AVTX stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $AVTX stock by insiders over the last 6 months:
- MITTIE DOYLE (Chief Medical Officer) has made 0 purchases and 3 sales selling 30,141 shares for an estimated $493,979.
- CHRISTOPHER RYAN SULLIVAN (Chief Financial Officer) has made 0 purchases and 6 sales selling 32,874 shares for an estimated $493,182.
- JONATHAN GOLDMAN has made 0 purchases and 2 sales selling 11,367 shares for an estimated $162,936.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$AVTX Revenue
$AVTX had revenues of $59K in Q4 2025. This is a decrease of -69.27% from the same period in the prior year.
You can track AVTX financials on Quiver Quantitative's AVTX stock page.
$AVTX Hedge Fund Activity
We have seen 57 institutional investors add shares of $AVTX stock to their portfolio, and 27 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 664,164 shares (+139.0%) to their portfolio in Q1 2026, for an estimated $9,915,968
- MILLENNIUM MANAGEMENT LLC added 522,548 shares (+380.2%) to their portfolio in Q4 2025, for an estimated $9,489,471
- JENNISON ASSOCIATES LLC added 475,625 shares (+inf%) to their portfolio in Q4 2025, for an estimated $8,637,350
- MARSHALL WACE, LLP added 451,541 shares (+806.2%) to their portfolio in Q4 2025, for an estimated $8,199,984
- SOLEUS CAPITAL MANAGEMENT, L.P. added 441,978 shares (+inf%) to their portfolio in Q4 2025, for an estimated $8,026,320
- POINT72 ASSET MANAGEMENT, L.P. removed 426,481 shares (-40.5%) from their portfolio in Q4 2025, for an estimated $7,744,894
- BALYASNY ASSET MANAGEMENT L.P. removed 378,124 shares (-46.3%) from their portfolio in Q4 2025, for an estimated $6,866,731
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
